A natural vision for parenteral & dialysis solutions
Our solutions for parenteral and dialysis solutions are based on the highest quality sodium lactate and calcium gluconate.
We produce our pharmaceutical-grade lactic acid through the natural fermentation of carbohydrates and based on the most stringent purification techniques; produced under cGMP conditions; and compliant with the highest quality standards (including DMF, CEP, CTD).
PURASAL for parenteral and dialysis
A growing number of dialysis solutions (IV, CAPD) uses our pharma-grade natural lactic acid and sodium-S-lactate - PURASAL S/PF® (the sodium-S-lactate acts as an electrolyte or alkalinizing agent) as API.
Calcium Gluconate Injectable
Whether it’s preventing acute hypocalcaemia in humans or tackling milk fever in cows, our Calcium Gluconate Injectable is an ideal API.
Putting quality first
Our pharma customers are guaranteed the highest and most consistent quality based on the very latest regulatory standards, and supported by a world-class supply chain. Our experienced team of Quality & Regulatory experts can help you with everything from manufacturing to preparing essential documentation.
Certificate of Suitability: What makes us unique?
We are currently the only supplier of calcium lactate with a Certificate of Suitability (CEP) – granted by the European Directorate for the Quality of Medicines in Strasbourg. What’s more, calcium lactate can be registered as an Active Pharmaceutical Ingredient as well as an excipient.
Product not available in your region
This product is not available in the selected region.
If you want this product in your region, or find a suitable alternative, please contact us,
News & Events
3/2/2021 8:00 AM
Corbion Further Boosts Lactic Acid Capacity Through Concurrent Expansion Projects
Multiple productivity initiatives will increase supply of lactic acid, a nature-based ingredient, for the company's
1/21/2021 8:00 AM
Corbion to Expand Lactic Acid Capacity in North America
Investment to increase production capacity demonstrates company's commitment to regional customers and to meeting their
2/25/2019 11:24 AM
New SENTIALL® Co-polymer Platform from Corbion to Unlock Value in Multiple Industries
Self-healing concrete application demonstrates how SENTIALL® biotechnology can leverage controlled release capabilities to enable unprecedented